Bacterial resistance and antimicrobial therapy in respiratory medicine and critical care

Medicina

Volumn 61, Issue 5 I, 2001, Pages 603-613

  Luna, C M ^a   Gherardi, C ^a   Famiglietti, A ^a   Vay, C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antibiotic resistance; Antibiotics; Critical care; Multi drug resistance; Nosocomial infection; Pneumonia

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CARBENICILLIN; CEFEPIME; CEFOTETAN; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CLAVULANIC ACID; COTRIMOXAZOLE; ENZYME; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; MACROLIDE; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULBACTAM; TAZOBACTAM; TETRACYCLINE; UNINDEXED DRUG; UREIDOPENICILLIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL MEMBRANE; CAUSE OF DEATH; CHEMICAL MODIFICATION; CHEMOPROPHYLAXIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DIAGNOSIS; DISEASE SEVERITY; DRUG COMBINATION; DRUG THERAPY; DRUG USE; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENZYME INACTIVATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE; INTENSIVE CARE UNIT; INTERNAL MEDICINE; MEMBRANE PERMEABILITY; MICROBIOLOGY; MICROORGANISM; MORTALITY; PLASMID; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; STAPHYLOCOCCUS AUREUS; BACTERIAL PNEUMONIA; CROSS INFECTION; MULTIDRUG RESISTANCE; RESPIRATORY TRACT INFECTION; REVIEW;

CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENGLISH ABSTRACT; HUMAN; INTENSIVE CARE UNITS; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT INFECTIONS;

EID: 0035168715     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Trends in infectious diseses mortality in the United States
2. The antibiotic paradox: How miracle drugs are destroying the miracle
3. Incidence and nature of endemic and epidemic nosocomial infections
4. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
5. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques
6. Impact of BAL data on the therapy and outcome of ventilator associated pneumonia
7. The prevalence of nosocomial infection in intensive care units in Europe
8. Overview of resistance in the 1990s
9. A comparative analysis of patients with early-onset nosocomial pneumonia in the ICU setting
10. The impact of antimicrobial use on the emergence of antimicrobial-resistant abacteria in hospitals
11. Deaths from nosocomial infections: Experience in an university hospital and community hospital
12. The effect of late-onset ventilator-associated pneumonia in determining patient mortality
13. Ventilator associated neumonia due to Pseudomonas aeruginosa
14. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit
15. Antimicrobial resistance in the intensive care unit
16. The challenges of emerging infectious diseases
17. Antimicrobial-drug resistance
18. A 3-year survey study of bacterial resistance in Argentina from a national program
19. Data summary from October 1996-April 1997
20. Antibiotic resisteance. Problems in the critical care Unit
21. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
22. Subcomisión de Antimicrobianos de SADEBAC, AAM., Sistema informático de resistencia (SIR), análisis comparativo de dos cortes de prevalencia durante el año 1998
23. Mechanisms of bacterial antibiotic resistance
24. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
25. Aminoglycoside resistance and aminoglycoside usage: Ten years of experience in one hospital
26. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Kelbsiella
27. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes
28. Extended-spectrum -lactamases: A call for improved detection and control
29. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
30. American College of Chest Physicians/Society of Critical care medicine Consensus Conference: Definitions for sepsis and multiple-organ failure and guidelines for the use of innovative therapies in sepsis
31. Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia
32. Invasive diagnostic testing is not needed routinely to manage ventilator associated pneumonia
33. Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia
34. Antimicrobial misuse, antibiotic policies and information resources
35. Problems in antibiotic usage
36. Considerations in antimicrobial prescribing
37. Hospital Infection Control Practices Advisory Committee, Guideline for isolation precautions in hospitals. Part 1. Evolution of isolation practices
38. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals
39. Nosocomial pulmonary infection by antimicrobial-resistant bacteria of patients hospitalized in intensive care units: Risk factors and survival
40. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
41. Role of different routes for tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation
42. A model of the transmission of antibiotic-resistant bacteria in the intensive care unit
43. Does antibiotic restriction prevent resistance?
44. Antibiotic resistance. Control strategies
45. Scheduled change of antibiotics classes: A strategy to decrease the incidence of ventilator associated pneumonia
46. Antibiotic resistance. Squeezing the balloon?
47. Is «crop rotation» of antibiotics the solution to a «resistant» problem in the ICU?
48. Stomach as a source of colonization of the respiratory tract during mechanical ventilation: Association with ventilator-associated pneumonia
49. A randomized, double-blind placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit
50. Nosocomial pneumonia. Diagnosis and prevention
51. Selective digestive decontamination in multiple trauma patients: Cost and efficacy
52. Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD)
53. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: A challenge to hospital leadership
54. Changing physicians' practices (carta)
55. Resistencia bacteriana y tratamiento antibiótico en terapia intensiva